PRTFDC1 抗体 (AA 151-225) (Cy5)
Quick Overview for PRTFDC1 抗体 (AA 151-225) (Cy5) (ABIN6984480)
抗原
See all PRTFDC1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 151-225
-
交叉反应
- 大鼠
-
预测反应
- Human,Dog,Pig,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human PRTFDC1
-
亚型
- IgG
-
-
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (AA 2-225) antibody
PRTFDC1 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (Internal Region) antibodyPRTFDC1 适用: 人, 大鼠, 小鼠 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (AA 1-225) antibodyPRTFDC1 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (AA 150-199) antibodyPRTFDC1 适用: 人, 马, 兔, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (N-Term) antibodyPRTFDC1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-phosphoribosyl Transferase Domain Containing 1 (PRTFDC1) (Middle Region) antibodyPRTFDC1 适用: 人, 大鼠, Pig, 马, 兔, 犬, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- PRTFDC1 (phosphoribosyl Transferase Domain Containing 1 (PRTFDC1))
-
别名
- PRTFDC1
-
背景
- Optional[synonyms]: FLJ11888, HHGP, OTTHUMP00000019332, Phosphoribosyl transferase domain containing 1, phosphoribosyltransferase domain containing protein 1, Phosphoribosyltransferase domain-containing protein 1, PRDC1_HUMAN, prtfdc1, Uncharacterized protein PRTFDC1.
-
基因ID
- 56952
-
UniProt
- Q9NRG1
-
途径
- Ribonucleoside Biosynthetic Process
抗原
-
